June 18, 2015 | Pluristem Therapeutics, an Israeli company developing placenta-based therapy products, announced that it was awarded a NIS 11 million (approx. $2.9 million) from the Office of the Chief Scientist. The grant will go towards research and development for 2015. Pluristem was founded in 2001 by Shai Meretzki.
Related posts
Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023
Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
US Soldiers, Vets To Get Israeli-Made Helmets To Treat Depression
September 27, 2023
Facebook comments